Oligomannate , A New Oral Treatment For Mild To Moderate Alzheimer's Disease The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 2, 2019 /PRNewswire/ -- Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products...
from PR Newswire: https://ift.tt/2NBkM7P
No comments:
Post a Comment